Stay updated with breaking news from 68230a10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Achieve Life Sciences (NASDAQ:ACHV – Get Rating) had its target price reduced by Lake Street Capital from $22.00 to $19.00 in a report issued on Wednesday morning, The Fly reports. Several other research analysts have also recently weighed in on the stock. Oppenheimer reiterated an outperform rating and set a $17.00 price target on shares […]
Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) CEO John Bencich purchased 5,000 shares of the business’s stock in a transaction on Tuesday, May 30th. The stock was acquired at an average price of $5.50 per share, with a total value of $27,500.00. Following the purchase, the chief executive officer now directly owns 66,730 shares […]
Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) CEO John Bencich purchased 5,000 shares of the stock in a transaction that occurred on Tuesday, May 30th. The stock was bought at an average cost of $5.50 per share, with a total value of $27,500.00. Following the acquisition, the chief executive officer now owns 66,730 shares […]
Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) was the target of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 633,200 shares, a growth of 11.2% from the April 30th total of 569,600 shares. Based on an average daily trading volume, of 156,300 […]
Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) – Stock analysts at Zacks Small Cap issued their Q2 2023 earnings per share estimates for shares of Achieve Life Sciences in a research note issued on Wednesday, May 10th. Zacks Small Cap analyst J. Vandermosten forecasts that the biopharmaceutical company will earn ($0.40) per share for […]